Literature DB >> 29794618

A Flawed Design Produces Flawed Results.

Gary Peltz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29794618      PMCID： PMC5978761          DOI： 10.1097/ADM.0000000000000394

Source DB:  PubMed          Journal:  J Addict Med        ISSN： 1932-0620            Impact factor:   3.702


× No keyword cloud information.
  8 in total

1.  Site(s) and mechanisms of the anti-emetic action of 5-HT3 receptor antagonists: a discussion of Professor Naylor's paper.

Authors:  M B Tyers
Journal:  Br J Cancer Suppl       Date:  1992-12

2.  Palonosetron and hydroxyzine pre-treatment reduces the objective signs of experimentally-induced acute opioid withdrawal in humans: a double-blinded, randomized, placebo-controlled crossover study.

Authors:  Matthew J Erlendson; Nicole D'Arcy; Ellen M Encisco; Jeffrey J Yu; Lorena Rincon-Cruz; Gary Peltz; J David Clark; Larry F Chu
Journal:  Am J Drug Alcohol Abuse       Date:  2016-08-11       Impact factor: 3.829

3.  Ondansetron Does Not Reduce Withdrawal in Patients With Physical Dependence on Chronic Opioid Therapy.

Authors:  Larry F Chu; John Sun; Anna Clemenson; Matthew J Erlendson; Tom Rico; Erika Cornell; Hannah Obasi; Zahra N Sayyid; Ellen M Encisco; Jeff Yu; Jamison G Gamble; Ian Carroll; J David Clark
Journal:  J Addict Med       Date:  2017 Sep/Oct       Impact factor: 3.702

4.  From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics.

Authors:  Larry F Chu; De-Yong Liang; Xiangqi Li; Peyman Sahbaie; Nicole D'arcy; Guochun Liao; Gary Peltz; J David Clark
Journal:  Pharmacogenet Genomics       Date:  2009-03       Impact factor: 2.089

Review 5.  Mechanism of the anti-emetic activity of 5-HT3 receptor antagonists.

Authors:  M B Tyers; A J Freeman
Journal:  Oncology       Date:  1992       Impact factor: 2.935

6.  Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study.

Authors:  Russell K Portenoy; Jay Thomas; Michele L Moehl Boatwright; Diep Tran; Frank L Galasso; Nancy Stambler; Charles F Von Gunten; Robert J Israel
Journal:  J Pain Symptom Manage       Date:  2008-05       Impact factor: 3.612

7.  Methylnaltrexone for opioid-induced constipation in advanced illness.

Authors:  Jay Thomas; Sloan Karver; Gail Austin Cooney; Bruce H Chamberlain; Charles Kevin Watt; Neal E Slatkin; Nancy Stambler; Alton B Kremer; Robert J Israel
Journal:  N Engl J Med       Date:  2008-05-29       Impact factor: 91.245

8.  Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers.

Authors:  K H Simpson; P Murphy; P V Colthup; P Whelan
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.